|
End-of-day quote
Shanghai S.E.
2026-09-02
|
5-day change | 1st Jan Change | ||
| 8.520 CNY | -1.16% |
|
-0.47% | -32.17% |
| 08-21 | KPC Pharmaceuticals,Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-27 | KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs | MT |
| Market Cap | 6.45B 960M 828M 780M 711M 1.33B 90.65B 1.34B 9.23B 3.58B 46.35B 3.6B 3.52B 152B | P/E 2026 * |
39.9x | P/E 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 6.45B 960M 828M 780M 711M 1.33B 90.65B 1.34B 9.23B 3.58B 46.35B 3.6B 3.52B 152B | EV / Sales 2026 * |
1.14x | EV / Sales 2027 * | 1.03x |
| Free-Float |
60.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.16% | ||
| 1 week | -0.47% | ||
| Current month | -0.58% | ||
| 1 month | -6.06% | ||
| 3 months | -10.03% | ||
| 6 months | -30.62% | ||
| Current year | -32.17% |
| 1 week | 8.47 |  | 8.77 |
| 1 month | 8.28 | | 9.65 |
| Current year | 7.45 | | 13.55 |
| 1 year | 7.45 | | 14.57 |
| 3 years | 7.45 | | 24.11 |
| 5 years | 7.45 | | 26.09 |
| 10 years | 5.95 | | 26.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Sun
DFI | Director of Finance/CFO | - | 2023-01-02 |
Wei Yan
PSD | President | 55 | 2023-09-27 |
Wen Sen Zhang
PRN | Corporate Officer/Principal | 54 | 2007-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Liu
BRD | Director/Board Member | 74 | 2018-11-01 |
Lin Xi Li
BRD | Director/Board Member | 50 | 2018-11-01 |
Wen Sen Zhang
BRD | Director/Board Member | 54 | 2018-11-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | -0.47% | -40.25% | -45.52% | 971M | |
| +0.25% | -2.07% | +58.44% | +108.68% | 1,034B | |
| +1.36% | +1.89% | +54.50% | +71.22% | 654B | |
| +0.35% | -0.85% | +23.00% | +78.41% | 459B | |
| +0.49% | -5.19% | +33.28% | +35.53% | 343B | |
| +0.27% | +3.26% | +29.76% | +47.50% | 307B | |
| +0.12% | -2.11% | +0.60% | +12.03% | 251B | |
| +0.46% | -0.05% | +53.39% | +73.26% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.97% | 202B | |
| -0.04% | +1.17% | +32.90% | +99.29% | 186B | |
| Average | +0.50% | -2.73% | +22.98% | +42.64% | 367.26B | |
| Weighted average by Cap. | +0.65% | -3.31% | +38.89% | +67.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.66B 842M 727M 684M 624M 1.17B 79.55B 1.17B 8.1B 3.14B 40.67B 3.16B 3.09B 134B | 6.27B 934M 805M 759M 691M 1.29B 88.19B 1.3B 8.98B 3.49B 45.09B 3.51B 3.43B 148B |
| Net income | 164M 24.34M 21M 19.78M 18.02M 33.69M 2.3B 33.94M 234M 90.9M 1.18B 91.41M 89.41M 3.86B | 336M 49.97M 43.11M 40.61M 37M 69.15M 4.72B 69.67M 481M 187M 2.41B 188M 184M 7.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | CN¥8.520 | -1.16% | 5,557,900 |
| 26-09-01 | CN¥8.620 | +0.58% | 4,870,300 |
| 26-08-31 | CN¥8.570 | -1.61% | 4,827,400 |
| 26-08-28 | CN¥8.710 | +0.81% | 6,181,510 |
| 26-08-27 | CN¥8.640 | -0.58% | 7,075,102 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600422 Stock
Select your edition
All financial news and data tailored to specific country editions
